2018 Q1 Form 10-Q Financial Statement

#000156459018011920 Filed on May 08, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $13.56M $7.006M
YoY Change 93.61% -8.2%
Cost Of Revenue $7.330M $3.694M
YoY Change 98.43% -13.35%
Gross Profit $6.234M $3.312M
YoY Change 88.22% -1.69%
Gross Profit Margin 45.96% 47.27%
Selling, General & Admin $13.61M $13.68M
YoY Change -0.56% 16.48%
% of Gross Profit 218.27% 413.13%
Research & Development $9.437M $9.150M
YoY Change 3.14% 32.28%
% of Gross Profit 151.38% 276.27%
Depreciation & Amortization $413.0K $469.0K
YoY Change -11.94% -1.47%
% of Gross Profit 6.62% 14.16%
Operating Expenses $23.04M $22.83M
YoY Change 0.92% 22.01%
Operating Profit -$13.36M -$18.09M
YoY Change -26.19% 17.91%
Interest Expense $915.0K $531.0K
YoY Change 72.32% -18.93%
% of Operating Profit
Other Income/Expense, Net -$476.0K -$470.0K
YoY Change 1.28% -33.43%
Pretax Income -$13.83M -$18.56M
YoY Change -25.49% 15.65%
Income Tax $54.00K $35.00K
% Of Pretax Income
Net Earnings -$13.89M -$18.60M
YoY Change -25.34% 10.29%
Net Earnings / Revenue -102.37% -265.46%
Basic Earnings Per Share -$0.11 -$0.18
Diluted Earnings Per Share -$0.11 -$0.18
COMMON SHARES
Basic Shares Outstanding 124.8M 103.6M
Diluted Shares Outstanding 124.8M 103.6M

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $105.9M $53.80M
YoY Change 96.84% -41.08%
Cash & Equivalents $17.69M $11.19M
Short-Term Investments $91.00M $42.80M
Other Short-Term Assets $4.300M $3.461M
YoY Change 24.24% -45.35%
Inventory $13.20M $12.90M
Prepaid Expenses
Receivables $10.50M $5.600M
Other Receivables $0.00 $0.00
Total Short-Term Assets $133.8M $75.72M
YoY Change 76.7% -36.6%
LONG-TERM ASSETS
Property, Plant & Equipment $2.000M $2.842M
YoY Change -29.63% -15.92%
Goodwill $1.316M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.900M $4.113M
YoY Change 67.76% 75.69%
Total Long-Term Assets $10.60M $9.221M
YoY Change 14.95% 8.47%
TOTAL ASSETS
Total Short-Term Assets $133.8M $75.72M
Total Long-Term Assets $10.60M $9.221M
Total Assets $144.4M $84.94M
YoY Change 70.0% -33.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.20M $8.789M
YoY Change 27.43% 40.89%
Accrued Expenses $9.700M $9.492M
YoY Change 2.19% 2.94%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.400M $7.700M
YoY Change -81.82% 71.11%
Total Short-Term Liabilities $23.70M $26.44M
YoY Change -10.38% 15.89%
LONG-TERM LIABILITIES
Long-Term Debt $28.40M $10.50M
YoY Change 170.48% -31.37%
Other Long-Term Liabilities $6.800M $1.622M
YoY Change 319.24% 23.44%
Total Long-Term Liabilities $35.20M $1.622M
YoY Change 2070.16% 23.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.70M $26.44M
Total Long-Term Liabilities $35.20M $1.622M
Total Liabilities $58.80M $43.45M
YoY Change 35.32% -2.14%
SHAREHOLDERS EQUITY
Retained Earnings -$679.3M
YoY Change 10.52%
Common Stock $720.9M
YoY Change 3.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $85.60M $41.49M
YoY Change
Total Liabilities & Shareholders Equity $144.4M $84.94M
YoY Change 70.0% -33.61%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$13.89M -$18.60M
YoY Change -25.34% 10.29%
Depreciation, Depletion And Amortization $413.0K $469.0K
YoY Change -11.94% -1.47%
Cash From Operating Activities -$10.33M -$16.35M
YoY Change -36.85% 25.38%
INVESTING ACTIVITIES
Capital Expenditures $52.00K $185.0K
YoY Change -71.89% 330.23%
Acquisitions
YoY Change
Other Investing Activities -$44.69M $5.860M
YoY Change -862.63% -113.01%
Cash From Investing Activities -$44.74M $5.680M
YoY Change -887.73% -112.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $57.56M
YoY Change
Debt Paid & Issued, Net $32.00K $1.271M
YoY Change -97.48% 3871.88%
Cash From Financing Activities 58.83M -880.0K
YoY Change -6784.89% -111.18%
NET CHANGE
Cash From Operating Activities -10.33M -16.35M
Cash From Investing Activities -44.74M 5.680M
Cash From Financing Activities 58.83M -880.0K
Net Change In Cash 3.759M -11.55M
YoY Change -132.55% -77.02%
FREE CASH FLOW
Cash From Operating Activities -$10.33M -$16.35M
Capital Expenditures $52.00K $185.0K
Free Cash Flow -$10.38M -$16.54M
YoY Change -37.24% 26.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
13564000
CY2018Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7330000
CY2017Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
3694000
CY2018Q1 cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
5400000
CY2017Q1 cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
3200000
CY2018Q1 cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
6234000
CY2017Q1 cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
3312000
CY2018Q1 us-gaap Contracts Revenue
ContractsRevenue
3455000
CY2017Q1 us-gaap Contracts Revenue
ContractsRevenue
1428000
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
124814000
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
413000
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103564000
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124814000
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103564000
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-329000
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-246000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14214000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18844000
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
469000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2315000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2147000
CY2018Q1 cers Non Cash Interest Expense
NonCashInterestExpense
269000
CY2017Q1 cers Non Cash Interest Expense
NonCashInterestExpense
195000
CY2018Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1000
CY2017Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7000
CY2017Q1 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
18000
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1926000
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1285000
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1224000
CY2018Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
9437000
CY2017Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
9150000
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13607000
CY2017Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13683000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
23044000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
22833000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13355000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-18093000
CY2018Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
108000
CY2017Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-45000
CY2018Q1 us-gaap Interest Expense
InterestExpense
915000
CY2017Q1 us-gaap Interest Expense
InterestExpense
531000
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
331000
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
106000
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-476000
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-470000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13831000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18563000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-13885000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-18598000
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
388000
CY2018Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1475000
CY2017Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
310000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-122000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
198000
CY2018Q1 cers Increase Decrease In Accrued Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities
-1341000
CY2017Q1 cers Increase Decrease In Accrued Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities
-1724000
CY2018Q1 cers Increase Decrease In Manufacturing And Development Payment Liability
IncreaseDecreaseInManufacturingAndDevelopmentPaymentLiability
164000
CY2017Q1 cers Increase Decrease In Manufacturing And Development Payment Liability
IncreaseDecreaseInManufacturingAndDevelopmentPaymentLiability
76000
CY2018Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
186000
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
313000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-10325000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-16348000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
52000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
185000
CY2018Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
56941000
CY2017Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
10158000
CY2018Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
12250000
CY2017Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
16018000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-44743000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
5675000
CY2018Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1295000
CY2017Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
422000
CY2018Q1 cers Payments For Proceeds From Issuance Of Common Stock
PaymentsForProceedsFromIssuanceOfCommonStock
-57564000
CY2017Q1 cers Payments For Proceeds From Issuance Of Common Stock
PaymentsForProceedsFromIssuanceOfCommonStock
30000
CY2018Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
32000
CY2017Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1271000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
58827000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-879000
CY2018Q1 cers Cash Cash Equivalents And Restricted Cash Period Increase Decrease
CashCashEquivalentsAndRestrictedCashPeriodIncreaseDecrease
3759000
CY2017Q1 cers Cash Cash Equivalents And Restricted Cash Period Increase Decrease
CashCashEquivalentsAndRestrictedCashPeriodIncreaseDecrease
-11552000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13930000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22744000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17689000
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11192000
CY2018Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates, including those related to the nature and timing of satisfaction of performance obligations, the timing when the customer obtains control of products or services, the standalone selling price (&#8220;SSP&#8221;) of performance obligations, variable consideration, accounts receivable, inventory reserves, fair values of investments, stock-based compensation, intangible assets and goodwill, useful lives of intangible assets and property and equipment, income taxes, and accrued liabilities, among others. The Company bases its estimates on historical experience, future projections, and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions.</p></div>
CY2018Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, available-for-sale securities and accounts receivable.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the Company&#8217;s investment policy, substantially all of the Company&#8217;s cash, cash equivalents and available-for-sale securities are maintained at major financial institutions of high credit standing. The Company monitors the financial credit worthiness of the issuers of its investments and limits the concentration in individual securities and types of investments that exist within its investment portfolio. Generally, all of the Company&#8217;s investments carry high credit quality ratings, which is in accordance with its investment policy. At March&#160;31, 2018, the Company does not believe there is significant financial risk from non-performance by the issuers of the Company&#8217;s cash equivalents and short-term investments.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of credit risk with respect to trade receivables exist. On a regular basis, including at the time of sale, the Company performs credit evaluations of its significant customers that it expects to sell to on credit terms. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company establishes an allowance for doubtful accounts against the accounts receivable on its unaudited condensed consolidated balance sheets and records a charge on its unaudited condensed consolidated statements of operations as a component of selling, general and administrative expenses.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company had three customers that accounted for more than 10% of the Company&#8217;s outstanding trade receivables at both March&#160;31, 2018 and December&#160;31, 2017. These customers cumulatively represented approximately 57% and 53% of the Company&#8217;s outstanding trade receivables at March&#160;31, 2018 and December&#160;31, 2017, respectively. To date, the Company has not experienced collection difficulties from these customers.</p></div>
CY2018Q1 cers Work In Process Inventory Life Period
WorkInProcessInventoryLifePeriod
P1Y
CY2018Q1 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Guarantee and Indemnification Arrangements</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes the fair value for guarantee and indemnification arrangements issued or modified by the Company. In addition, the Company monitors the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has occurred. If the Company determines it is probable that a loss has occurred, then any such estimable loss would be recognized under those guarantees and indemnifications. Some of the agreements that the Company is a party to contain provisions that indemnify the counter party from damages and costs resulting from claims that the Company&#8217;s technology infringes the intellectual property rights of a third party or claims that the sale or use of the Company&#8217;s products have caused personal injury or other damage or loss. The Company has not received any such requests for indemnification under these provisions and has not been required to make material payments pursuant to these provisions.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company generally provides for a one-year warranty on certain of its INTERCEPT blood-safety products covering defects in materials and workmanship. The Company accrues costs associated with warranty obligations when claims become known and are estimable. The Company has not experienced significant or systemic warranty claims nor is it aware of any existing current warranty claims. Accordingly, the Company had not accrued for any future warranty costs for its products at March&#160;31, 2018 and December&#160;31, 2017.</p></div>
CY2018Q1 us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
The Company invoices its customers based upon the payment terms in the contracts, which is generally from 30 to 60 days.
CY2018Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2017Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
149000
CY2018Q1 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
662000
CY2017Q1 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
634000
CY2018Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
468000
CY2017Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
313000
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
470000
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
15000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
46000
CY2018Q1 cers Deferred Revenue Deductions Non Current
DeferredRevenueDeductionsNonCurrent
8000
CY2017Q1 cers Deferred Revenue Deductions Non Current
DeferredRevenueDeductionsNonCurrent
8000
CY2018Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
7000
CY2017Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
38000
CY2018Q1 us-gaap Restricted Cash
RestrictedCash
2500000
CY2018Q1 cers Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
3
CY2017Q4 cers Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
3
CY2018Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
200000
CY2017Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
200000
CY2018Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1530
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1480
CY2018Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P10Y
CY2018Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2018Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2017Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19550000
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17635000
CY2018Q1 cers Product Warranty Term
ProductWarrantyTerm
P1Y
CY2018Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0
CY2017Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0
CY2018Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
93901000
CY2018Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
426000
CY2018Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
93475000
CY2017Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
50868000
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
97000
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
50771000
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
31278000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
38836000
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
62623000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
12032000
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
31175000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
38781000
CY2018Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
62300000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
11990000
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
89738000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
44514000
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
426000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
97000
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
89738000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
44514000
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
426000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
97000
CY2018Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2017Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2018Q1 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
CY2018Q1 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2017Q1 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2018Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3434000
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4299000
CY2018Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9731000
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10158000
CY2018Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5613000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7372000
CY2018Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3006000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2605000
CY2018Q1 cers Accrued Customer Costs Current
AccruedCustomerCostsCurrent
696000
CY2017Q4 cers Accrued Customer Costs Current
AccruedCustomerCostsCurrent
481000
CY2018Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
254000
CY2017Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
507000
CY2018Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
788000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
747000
CY2018Q1 cers Long Term Debt Maturities Repayments Of Interest In Year Four
LongTermDebtMaturitiesRepaymentsOfInterestInYearFour
882000
CY2018Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
7857000
CY2018Q1 cers Long Term Debt Maturities Repayments Of Principal And Interest In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearFive
7552000
CY2018Q1 cers Long Term Debt Maturities Repayments Of Interest In Year Five
LongTermDebtMaturitiesRepaymentsOfInterestInYearFive
2552000
CY2018Q1 cers Long Term Debt Maturities Repayments Of Interest
LongTermDebtMaturitiesRepaymentsOfInterest
9616000
CY2018Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
8571000
CY2018Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
8572000
CY2018Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
5000000
CY2018Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
30000000
CY2018Q1 cers Longterm Debt Maturities Repayments Of Interest In Next Twelve Months
LongtermDebtMaturitiesRepaymentsOfInterestInNextTwelveMonths
2062000
CY2018Q1 cers Long Term Debt Maturities Repayments Of Interest In Year Two
LongTermDebtMaturitiesRepaymentsOfInterestInYearTwo
2447000
CY2018Q1 cers Long Term Debt Maturities Repayments Of Interest In Year Three
LongTermDebtMaturitiesRepaymentsOfInterestInYearThree
1673000
CY2018Q1 cers Accrual For Manufacturing Of Entity Products
AccrualForManufacturingOfEntityProducts
4930000
CY2018Q1 cers Long Term Debt Maturities Repayments Of Principal And Interest In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInNextTwelveMonths
2062000
CY2018Q1 cers Long Term Debt Maturities Repayments Of Principal And Interest In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearTwo
10304000
CY2018Q1 cers Long Term Debt Maturities Repayments Of Principal And Interest In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearThree
10244000
CY2018Q1 cers Long Term Debt Maturities Repayments Of Principal And Interest In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearFour
9454000
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2110000
CY2018Q1 cers Long Term Debt Maturities Repayments Of Principal And Interest
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterest
39616000
CY2018Q1 cers Minimum Term Of Non Cancelable Operating Leases
MinimumTermOfNonCancelableOperatingLeases
P1Y
CY2018Q1 cers Expiration Of Non Cancelable Operating Leases Maximum Year
ExpirationOfNonCancelableOperatingLeasesMaximumYear
2029
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
1235000
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3135000
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2259000
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2141000
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
16045000
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
26925000
CY2010 cers Proceeds From Landlord Financing Leasehold Improvement
ProceedsFromLandlordFinancingLeaseholdImprovement
1100000
CY2018Q1 cers Accrued Leasehold Improvements Current And Accrued Leasehold Improvements Noncurrent
AccruedLeaseholdImprovementsCurrentAndAccruedLeaseholdImprovementsNoncurrent
200000
CY2017Q4 cers Accrual For Manufacturing Of Entity Products
AccrualForManufacturingOfEntityProducts
4687000
CY2018Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
1400000
CY2017Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
231000
CY2018Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1

Files In Submission

Name View Source Status
0001564590-18-011920-index-headers.html Edgar Link pending
0001564590-18-011920-index.html Edgar Link pending
0001564590-18-011920.txt Edgar Link pending
0001564590-18-011920-xbrl.zip Edgar Link pending
cers-10q_20180331.htm Edgar Link pending
cers-20180331.xml Edgar Link completed
cers-20180331.xsd Edgar Link pending
cers-20180331_cal.xml Edgar Link unprocessable
cers-20180331_def.xml Edgar Link unprocessable
cers-20180331_lab.xml Edgar Link unprocessable
cers-20180331_pre.xml Edgar Link unprocessable
cers-ex101_148.htm Edgar Link pending
cers-ex102_149.htm Edgar Link pending
cers-ex103_150.htm Edgar Link pending
cers-ex311_7.htm Edgar Link pending
cers-ex312_10.htm Edgar Link pending
cers-ex321_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g201805081620208072156.jpg Edgar Link pending
g201805081620208212157.jpg Edgar Link pending
g201805081620208412158.jpg Edgar Link pending
g201805081620208652159.jpg Edgar Link pending
g201805081620208882160.jpg Edgar Link pending
g201805081620212872161.jpg Edgar Link pending
g201805081620213102162.jpg Edgar Link pending
g201805081620231882163.jpg Edgar Link pending
g201805081620232132164.jpg Edgar Link pending
g201805081620239262165.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending